Inhalation Sciences: IRS order with large generic pharma company - Redeye

Redeye is positive for ISAB’s continued high sales activity. Today, the company announced it has signed a new IRS order worth SEK1.2m with a large generic pharma company. We look forward to the Q3’22 report at the end of November and reiterate our Base Case of SEK23.

Länk till analysen i sin helhet: https://www.redeye.se/research/860539/inhalation-sciences-irs-order-with-large-generic-pharma-company?utm_source=finwire&utm_medium=RSS